Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
750 Tumor extracellular matrix drives immunosuppressive macrophage polarization in clear cell renal cell carcinoma
5 affiliations
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- 21Yale School of Medicine, New Haven, CT, USA
- 3Yale School of Medicine, New Haven, CT, USA
- 4Yale University, New Haven, CT, USA
- 5Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA
Related
- Cardiac Extracellular Matrix derived from younger animals stabilizes macrophage inflammatory polarization through modulation of the interferon signaling pathway
- The Efferocytosis-Driven Macrophage Polarization: A Concerto in the Tumor Immunosuppressive Microenvironment.
- ANKRD22 Downregulation Reprograms Lipid Metabolism to Activate the Notch/Hes1 Pathway, Driving Immunosuppressive Macrophage Polarization in Colorectal Cancer.
- A macrophage-associated immunosuppressive subtype defined by Lactobacillus/Bifidobacterium-associated host genes characterizes prognosis and the immune microenvironment in hepatocellular carcinoma.
- HSP90AA1 induces M2 macrophage polarization via stabilizing ITGB1 and promoting CCL2 secretion in nasopharyngeal carcinoma
BibTeX
@article{choueiri2026tumor,
title = {{750 Tumor extracellular matrix drives immunosuppressive macrophage polarization in clear cell renal cell carcinoma}},
author = {Toni K Choueiri and Nicholas Schindler and Soki Kashima and Rishabh Rout and Zhaochen Ye and David A Braun and Katsuhiro Ito and Zachary A Yochum},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0750},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0750},
note = {CC BY},
}
RIS
TY - JOUR
TI - 750 Tumor extracellular matrix drives immunosuppressive macrophage polarization in clear cell renal cell carcinoma
AU - Toni K Choueiri
AU - Nicholas Schindler
AU - Soki Kashima
AU - Rishabh Rout
AU - Zhaochen Ye
AU - David A Braun
AU - Katsuhiro Ito
AU - Zachary A Yochum
PY - 2026
DA - 2026/11/08
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0750
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0750
SN - 2051-1426
ER -